Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
Submitted by
admin
on July 8, 2013 - 11:02am
Source:
Forbes
News Tags:
biotech
ONYX Pharmaceuticals
Celldex
Novavax
Puma Biotechnology
Endocyte
Alnylam
Bluebird Bio
Dyax
Medivation
Clovis Oncology
Achillion
Insmed
Arena Pharmaceuticals
Avanir
Receptos
Synergy Pharmaceuticals
ChemoCentryx
Idenix
MiMedx
Portola Pharmaceuticals
Headline:
The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
Do Not Allow Advertisers to Use My Personal information
